Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxiang Feng

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Thoracic Disease|May 1, 2018
A comparison between two lung ventilation with CO<sub>2</sub> artificial pneumothorax and one lung ventilation during thoracic phase of minimally invasive esophagectomyMiao Lin, Yaxing Shen, Hao Wang, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung AdenocarcinomaLongfu Zhang, Jie Liu, Dawei Yang, et al.
Journal of Surgical Oncology|May 26, 2017
Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registryXiaodong Yang, Fenghao Sun, Li Chen, et al.
Oncotargets and Therapy|June 28, 2017
Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysisMing Li, Xiaodong Yang, Yuhan Chen, et al.
Frontiers in Oncology|July 24, 2019
Survival and Long-Term Cause-Specific Mortality Associated With Stage IA Lung Adenocarcinoma After Wedge Resection vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk AnalysisMengnan Zhao, Tao Lu, Yiwei Huang, et al.
Translational Oncology|October 13, 2022
ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinomaHuan Zhang, Guangyao Shan, Xing Jin, et al.
Journal of Cancer Research and Clinical Oncology|March 30, 2020
Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysisMengnan Zhao, Zhencong Chen, Yuansheng Zheng, et al.
Seminars in Thoracic and Cardiovascular Surgery|July 30, 2022
Impact of a Ground-glass Opacity Component on c-Stage IA Lung AdenocarcinomaMing Li, Junjie Xi, Qihai Sui, et al.
Annals of Surgical Oncology|December 25, 2025
Computed Tomography-Pathology Deep Learning Model for the Precise Prediction of Recurrence in Pathological Stage IA Lung AdenocarcinomaLongfu Zhang, Weitao Ye, Yi Zhou, et al.
Immunogenetics|November 14, 2020
Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinomaMengnan Zhao, Ming Li, Zhencong Chen, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Thoracic Disease|May 1, 2018
A comparison between two lung ventilation with CO<sub>2</sub> artificial pneumothorax and one lung ventilation during thoracic phase of minimally invasive esophagectomyMiao Lin, Yaxing Shen, Hao Wang, et al.
Diagnostics (Basel, Switzerland)|July 29, 2023
A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung AdenocarcinomaLongfu Zhang, Jie Liu, Dawei Yang, et al.
Journal of Surgical Oncology|May 26, 2017
Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registryXiaodong Yang, Fenghao Sun, Li Chen, et al.
Oncotargets and Therapy|June 28, 2017
Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysisMing Li, Xiaodong Yang, Yuhan Chen, et al.
Frontiers in Oncology|July 24, 2019
Survival and Long-Term Cause-Specific Mortality Associated With Stage IA Lung Adenocarcinoma After Wedge Resection vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk AnalysisMengnan Zhao, Tao Lu, Yiwei Huang, et al.
Translational Oncology|October 13, 2022
ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinomaHuan Zhang, Guangyao Shan, Xing Jin, et al.
Journal of Cancer Research and Clinical Oncology|March 30, 2020
Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysisMengnan Zhao, Zhencong Chen, Yuansheng Zheng, et al.
Seminars in Thoracic and Cardiovascular Surgery|July 30, 2022
Impact of a Ground-glass Opacity Component on c-Stage IA Lung AdenocarcinomaMing Li, Junjie Xi, Qihai Sui, et al.
Annals of Surgical Oncology|December 25, 2025
Computed Tomography-Pathology Deep Learning Model for the Precise Prediction of Recurrence in Pathological Stage IA Lung AdenocarcinomaLongfu Zhang, Weitao Ye, Yi Zhou, et al.
Immunogenetics|November 14, 2020
Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinomaMengnan Zhao, Ming Li, Zhencong Chen, et al.
Pageof 7